MCGIRR DAVID W J
Insider CIK 1219023 · INSM Director · RLYP Director · ROKA Director · ASNS Director · MNLO Director · RYTM Director · CBST SVP & Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-06-24 | 2026-06-25 | 3,691 | — | $0 | 3,691 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-06-24 | 2026-06-25 | 2,324 | — | $0 | 2,324 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-06-23 | 2026-06-25 | 4,712 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-06-23 | 2026-06-25 | 4,712 | — | $0 | 11,712 | SEC↗ |
| INSM INSMED Inc | G Gift | 2026-02-09 | 2026-02-11 | 53,400 | — | $0 | 53,400 | SEC↗ |
| INSM INSMED Inc | G Gift | 2026-02-09 | 2026-02-11 | 53,400 | — | $0 | 44,323 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 4,712 | — | $0 | 4,712 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 7,037 | — | $0 | 7,037 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 7,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-06-09 | 2025-06-10 | 1,500 | — | $0 | 4,722 | SEC↗ |
| INSM INSMED Inc | S Sale | 2025-06-04 | 2025-06-04 | 3,000 | $73.27 | $219.8K | 97,723 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-03 | 2025-06-05 | 65,431 | — | $0 | 0 | SEC↗ |
| INSM INSMED Inc | S Sale | 2025-06-03 | 2025-06-04 | 3,250 | $71.30 | $231.7K | 100,723 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-06-03 | 2025-06-05 | 65,431 | $4.59 | $300.3K | 68,431 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-06-03 | 2025-06-05 | 55,558 | $65.15 | $3.62M | 12,873 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-06-03 | 2025-06-05 | 9,873 | $65.64 | $648.1K | 3,000 | SEC↗ |
| INSM INSMED Inc | A Award | 2025-05-15 | 2025-05-19 | 5,058 | — | $0 | 103,973 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 14,000 | — | $0 | 14,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-06-10 | 2024-06-11 | 45,000 | — | $0 | 96,667 | SEC↗ |
| INSM INSMED Inc | A Award | 2024-05-13 | 2024-05-15 | 13,162 | — | $0 | 98,915 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 14,000 | — | $0 | 14,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-06-13 | 2023-06-14 | 45,000 | — | $0 | 51,667 | SEC↗ |
| INSM INSMED Inc | A Award | 2023-05-11 | 2023-05-15 | 13,192 | — | $0 | 85,753 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-06-08 | 2022-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-06-06 | 2022-06-27 | 6,667 | — | $0 | 6,667 | SEC↗ |
| INSM INSMED Inc | A Award | 2022-05-11 | 2022-05-13 | 14,645 | — | $0 | 72,561 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2021-06-02 | 2021-06-02 | 6,000 | $9.50 | $57.0K | 6,000 | SEC↗ |
| INSM INSMED Inc | A Award | 2021-05-12 | 2021-05-14 | 7,558 | — | $0 | 57,916 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-06-17 | 2020-06-18 | 18,500 | — | $0 | 18,500 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-06-10 | 2020-06-11 | 3,427 | — | $0 | 3,427 | SEC↗ |
| INSM INSMED Inc | A Award | 2020-05-12 | 2020-05-14 | 8,097 | — | $0 | 50,358 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-08-08 | 22,500 | — | $0 | 65,780 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 22,500 | — | $0 | 65,780 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2019-06-19 | 2019-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-06-17 | 2019-06-19 | 3,427 | — | $0 | 3,427 | SEC↗ |
| INSM INSMED Inc | A Award | 2019-05-15 | 2019-05-16 | 6,899 | — | $0 | 42,261 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2018-06-06 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2018-06-05 | 2018-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INSM INSMED Inc | A Award | 2018-05-15 | 2018-05-17 | 6,066 | — | $0 | 35,362 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2017-11-15 | 2018-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2017-11-15 | 2017-12-01 | 7,324 | — | $0 | 7,324 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 3,000 | — | $0 | 3,000 | SEC↗ |
| INSM INSMED Inc | A Award | 2017-05-17 | 2017-05-19 | 6,702 | — | $0 | 29,296 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 55,232 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 3,828 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 10,140 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 2,729 | $32.00 | $87.3K | 2,250 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 2,250 | $32.00 | $72.0K | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-21 | 2016-06-23 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-21 | 2016-06-23 | 2,250 | — | $0 | 4,979 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-06-07 | 2016-06-08 | 1,013 | $19.34 | $19.6K | 2,729 | SEC↗ |
| INSM INSMED Inc | A Award | 2016-05-19 | 2016-05-23 | 12,742 | — | $0 | 22,594 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2015-06-24 | 2015-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-06-11 | 2015-06-15 | 1,220 | $34.67 | $42.3K | 3,742 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-06-04 | 2015-06-09 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-06-04 | 2015-06-09 | 2,250 | — | $0 | 4,962 | SEC↗ |
| INSM INSMED Inc | A Award | 2015-01-08 | 2015-01-09 | 6,222 | — | $0 | 9,852 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy | 2014-11-17 | 2014-11-17 | 20,994 | $3.65 | $76.6K | 50,000 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy | 2014-11-14 | 2014-11-17 | 29,006 | $3.57 | $103.6K | 29,006 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2014-10-31 | 2014-11-04 | 702 | — | $0 | 0 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2014-10-31 | 2014-11-04 | 702 | — | $0 | 3,630 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-06-19 | 2014-06-23 | 3,828 | — | $0 | 3,828 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2014-06-19 | 2014-06-23 | 2,712 | — | $0 | 2,712 | SEC↗ |
| INSM INSMED INC | A Award | 2014-01-10 | 2014-01-14 | 2,928 | — | $0 | 3,630 | SEC↗ |
| INSM INSMED INC | A Award deriv | 2013-10-31 | 2013-11-01 | 702 | — | $0 | 702 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-02-16 | 2013-02-20 | 1,500 | — | $0 | 4,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-02-16 | 2013-02-20 | 1,500 | — | $0 | 18,700 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-20 | 4,807 | — | $0 | 4,807 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-09-21 | 2012-09-24 | 15,000 | — | $0 | 10,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-09-21 | 2012-09-24 | 15,000 | $49.79 | $746.9K | 17,200 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-09-21 | 2012-09-24 | 15,000 | $10.35 | $155.3K | 32,200 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-08-24 | 2012-08-27 | 20,000 | — | $0 | 25,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-08-24 | 2012-08-27 | 20,000 | $10.35 | $207.0K | 37,200 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-08-24 | 2012-08-27 | 20,000 | $45.69 | $913.8K | 17,200 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-15 | 2012-05-16 | 1,600 | — | $0 | 1,600 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-15 | 2012-05-16 | 1,600 | — | $0 | 22,480 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 1,875 | — | $0 | 3,750 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 1,875 | — | $0 | 20,880 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-13 | 2012-05-15 | 1,400 | — | $0 | 4,200 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-13 | 2012-05-15 | 1,400 | — | $0 | 19,005 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-03-30 | 2012-04-03 | 260 | $43.25 | $11.2K | 17,605 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 15,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-02-23 | 2012-02-27 | 15,000 | $42.68 | $640.2K | 17,345 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-02-23 | 2012-02-27 | 15,000 | $12.61 | $189.2K | 32,345 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-16 | 2012-02-21 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-16 | 2012-02-21 | 37,500 | — | $0 | 37,500 | SEC↗ |